End-zit
NDC Package 68605-2003-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

End-zit is a . Marketed by Abbe Laboratories, Inc., this product is identified by NDC 68605-2003 and is authorized under FDA application part333D.

Identification & Billing

NDC Package Code
68605-2003-2
Package Description
17.57 g in 1 BOTTLE, GLASS
Product Code
68605-2003
11-Digit Billing Format
68605200302

Clinical Specifications

Proprietary Name
End-zit
Dosage Form
-

Regulatory & Marketing

Labeler Name
Abbe Laboratories, Inc.
FDA Application #
part333D
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
04-20-2004
End Marketing Date
01-01-2019
Listing Expiration
01-01-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68605-2003-2 identifies a specific commercial package of 17.57 g in 1 bottle, glass of End-zit, labeled by Abbe Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Abbe Laboratories, Inc. on April 20, 2004. The current certification is valid through January 01, 2019.

How is this Abbe Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68605200302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68605-2003-2
11-Digit CMS (5-4-2)
68605-2003-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.